19
Participants
Start Date
January 31, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
sarilumab SAR153191 (REGN88)
Pharmaceutical form:Prefilled syringe of sarilumab solution Route of administration: Subcutaneous injection
simvastatin
Pharmaceutical form:Film-coated 20 mg Tablet Route of administration: oral
Investigational Site Number 498001, Chisinau
Investigational Site Number 840002, Duncansville
Investigational Site Number 840003, Jackson
Investigational Site Number 840001, Dallas
Investigational Site Number 410002, Seoul
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY